The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.65
Bid: 3.50
Ask: 3.80
Change: 0.25 (7.35%)
Spread: 0.30 (8.571%)
Open: 3.43
High: 3.65
Low: 3.43
Prev. Close: 3.40
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PCA Dealing

10 Nov 2023 13:22

RNS Number : 1305T
Allergy Therapeutics PLC
10 November 2023

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

SkyGem Acquisition Limited

2

Reason for the notification

a)

Position / status

Person Closely Associated with Mr. Zheqing (Simon) Shen, Non-Executive Director of Allergy Therapeutics Plc

b)

Initial notification / amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Allergy Therapeutics plc

b)

LEI

213800PQ7AHK7KGVOE23

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001 each

ISIN: GB00B02LCQ05

b)

Nature of the transaction

Acquisition of Ordinary Shares pursuant to the mandatory offer

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.01

247,935,057

d)

Aggregated information

- Aggregated volume

- Price

n/a

e)

Date of the transaction

9 November 2023

f)

Place of the transaction

Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBMBJTMTBBBLJ
Date   Source Headline
23rd May 201211:23 amRNSVoluntary recall of Anapen by Lincoln Medical
17th May 20124:51 pmRNSHolding(s) in Company
17th May 20124:51 pmRNSHolding(s) in Company
16th May 201211:11 amRNSTotal Voting Rights
2nd May 20123:33 pmRNSBoard Appointment
24th Apr 201212:31 pmRNSHolding(s) in Company
20th Apr 20128:01 amRNSConcert Party Shareholding
20th Apr 20128:01 amRNSDirector/PDMR Shareholding
19th Apr 20123:05 pmRNSResult of AGM
18th Apr 20127:00 amRNSResult of Offer
30th Mar 20127:02 amRNSGrant of Options
30th Mar 20127:01 amRNSFundraising Announcement
30th Mar 20127:00 amRNSHalf Yearly Report
14th Mar 20129:23 amRNSNotice of results and shareholder update
21st Feb 20126:12 pmRNSHolding(s) in Company
21st Feb 20126:11 pmRNSHolding(s) in Company
6th Dec 20117:00 amRNSAnapen® 500mcg epinephrine auto-injector
28th Nov 20117:00 amRNSRegulatory update PEI FDA
16th Nov 20115:20 pmRNSAGM Statement
20th Oct 20116:24 pmRNSAnnual Financial Report
29th Sep 201112:45 pmRNSProvisional Grant of Options
19th Sep 20117:00 amRNSFinal Results
19th Sep 20117:00 amRNSDistribution Agreement
8th Sep 20115:06 pmRNSHolding(s) in Company
7th Sep 20117:00 amRNSNotice of Results
23rd Aug 20119:35 amRNSForm 8.3 - [Allergy Therapeutics]
23rd Aug 20117:00 amRNSAllergy Therapeutics enters Latin America
22nd Aug 201112:03 pmRNSForm 8.3 - [Allergy Therapeutics Plc]
8th Jun 20117:00 amRNSRegulatory Update
28th Apr 20117:00 amRNSTotal Voting Rights
26th Apr 20117:00 amRNSFDA Update
20th Apr 20112:59 pmRNSExercise of Options
11th Apr 20114:31 pmRNSHolding(s) in Company
7th Apr 20117:00 amRNSGrass MATA MPL dossier submitted in Switzerland
30th Mar 20116:19 pmRNSDirector/PDMR Shareholding
29th Mar 20113:19 pmRNSDirector/PDMR Shareholding
29th Mar 20113:17 pmRNSDirector/PDMR Shareholding
28th Mar 20117:02 amRNSU.S. regulatory update
28th Mar 20117:00 amRNSHalf Yearly Report
9th Feb 201110:32 amRNSHolding(s) in Company
9th Feb 201110:31 amRNSHolding(s) in Company
1st Dec 20107:00 amRNSTen further MAAs submitted in Germany
18th Nov 201011:52 amRNSResult of AGM
20th Oct 20108:06 amRNSAnnual Financial Report
4th Oct 20109:45 amRNSDirector/PDMR Shareholding
30th Sep 20103:21 pmRNSDirectorate Change
20th Sep 20107:00 amRNSFinal Results
26th Jul 201010:06 amRNSHolding(s) in Company
22nd Jul 201012:24 pmRNSTrading Statement
19th Jul 201012:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.